H19 expression in hepatic metastases from a range of human carcinomas. - sprookjes - yvandenbroek - TriplyDB

H19 expression in hepatic metastases from a range of human carcinomas.

H19 expression in hepatic metastases from a range of human carcinomas.

http://www.wikidata.org/entity/Q35588750

about

Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer Genome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chicken Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters.High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers.p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology The functional role of long non-coding RNA in human carcinomas.Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6.Involvement of long non-coding RNA in colorectal cancer: From benchtop to bedside (Review)Roles of long non-coding RNAs in gastric cancer metastasis Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets.CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA.Long non-coding RNA in cancer.Long non-coding RNAs in haematological malignancies.The non-coding transcriptome as a dynamic regulator of cancer metastasis The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine.LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2.Long non-coding RNAs in cancer invasion and metastasis.An emerging role for long non-coding RNAs in cancer metastasis Expression profiling of long non-coding RNA identifies linc-RoR as a prognostic biomarker in oral cancer.Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma.From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis.Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients.Long non-coding RNA in glioma: signaling pathways.Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer.Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues.Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value.MD-miniRNA could be a more accurate biomarker for prostate cancer screening compared with serum prostate-specific antigen level.Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment.Exosome: Function and Role in Cancer Metastasis and Drug Resistance.Long Non-Coding RNAs in Obesity-Induced Cancer

P2860

Q26751346-CE83E9D7-0CBC-4072-9914-B12DD2B8D2DA Q26775618-418A20F2-4157-4F49-9B51-F965CAEB5E73 Q27022048-B457F471-629A-4939-BC5F-63C2EC326AFE Q28384038-35217BE3-00F1-421D-A07F-0DD31DDF7086 Q30238915-5921178C-2FFC-473D-94CD-7D6E62C64A36 Q30467807-353479E0-29CA-4388-99BB-18F9E727AA42 Q31147380-3385FD6F-FCA8-4281-9788-8A682112E49D Q33597157-C0D93E57-676D-4531-9EC0-A32DE9CA8666 Q34339927-C6185BD0-05E1-4FF5-8876-28533D7CDED4 Q34605730-04967708-2348-4120-ABF3-FDF470125EC6 Q34995156-766AA8BE-F3E3-44A8-AC6C-14866897721C Q34998951-9B7B22E2-6723-4DA9-9B3B-A7DEF71FBE57 Q35042300-F456ECA0-7699-49A2-8275-C0890911CA62 Q35567632-AE9FFF9B-878A-45EA-8D6E-E2E919045DEB Q35747814-777CAC8E-BA71-4247-8629-C0F4911ADAA2 Q35954464-B243B2F8-3979-4FAC-8BBE-BFE34AE8E4CA Q36790436-2607383B-03D3-4EFB-AE48-3B1D7ACF4B52 Q37139037-73314D5D-B7CE-41E5-9B92-139E72817CC0 Q37705696-0F12B5DA-9B44-4E2C-BC16-8ABE53242954 Q38045210-65B527CB-B2D5-4A9F-B243-D05B4077A487 Q38176848-A712895D-A208-41E6-AD65-32BDE026CEA0 Q38219896-E2391A63-129D-46AA-BDAF-590D052E2CDA Q38237645-8B25A178-ADDE-4A1C-81CD-9CEF8AE9998D Q38706033-FD456D9A-2CAF-4FF5-B731-669BFF177069 Q38725370-7E54DFB3-143B-4B75-9ACA-CD8009C1F4B8 Q38732993-7E4B5A66-964B-46C9-AE1B-9C92B05789E4 Q38940586-C5A0EF09-8876-47DF-BB00-EBA3E3981455 Q39024684-C87E5AE7-FD54-4D6A-B101-AA65A17D5725 Q39130527-7E1CCBB4-41D3-4767-A6ED-0A88591F0053 Q39215101-9B3F060F-FE65-4E0E-ADDF-CB4F12027CD9 Q39327058-43633B6B-FFF9-4D97-84A8-5806EE3BD8F7 Q39547104-4645FC71-51E9-4D00-BEBD-8B59B1200EDA Q40452568-9C8AAAF6-0358-4E92-86DD-A00C2B345B34 Q41626983-F72C0A3E-322E-4587-A9CE-516781909D58 Q51746599-1B520882-C182-495D-8BD9-DB7736F6F366 Q52573928-C3EC41C6-9C84-4316-9380-9FC9431715BD Q55004964-FE2F2E19-6D66-4755-964A-D7D9BEFEFF3D Q58697396-CD690AD6-BD3F-44B1-BB4B-B9303CF69716

P2860

H19 expression in hepatic metastases from a range of human carcinomas.

http://www.wikidata.org/entity/Q35588750

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

H19 expression in hepatic metastases from a range of human carcinomas.

@ast

H19 expression in hepatic metastases from a range of human carcinomas.

@en

type

label

H19 expression in hepatic metastases from a range of human carcinomas.

@ast

H19 expression in hepatic metastases from a range of human carcinomas.

@en

prefLabel

H19 expression in hepatic metastases from a range of human carcinomas.

@ast

H19 expression in hepatic metastases from a range of human carcinomas.

@en

P1433

Q35588750-33BE06D1-5839-4152-9B9E-2EA0809F2981

P1476

Q35588750-A7442E5D-1293-4FF1-9A9B-C7979B518FC5

P2093

Q35588750-030D8EB9-41FF-4275-81C4-F0377F5A8A85

Q35588750-16F78F87-D5DB-41DC-8B47-0742C3E90C35

Q35588750-28C5D722-8362-40B0-9617-344ECBC91D02

Q35588750-3A426C69-9BAD-435B-ADE2-97C97290CFF8

Q35588750-3FBC2C47-7E5C-42B4-9ABE-8DA988293FB2

Q35588750-4F4E806B-CE97-450A-BD4E-9B42F30CFB04

Q35588750-A212EF58-84F5-41BB-9653-2381705E1E70

Q35588750-A9E93F0F-8F29-45FC-B7C4-F22AFD7B9710

Q35588750-AFEE0C8F-6D22-41CD-ABD7-CA1E3331CA57

Q35588750-E353F17F-CE33-4F5A-8D72-9AD88B10DF50

P2860

Q35588750-1E323BDD-B06B-44FF-BEF4-49A1204F7D43

Q35588750-2AC32840-C7CC-44E7-9640-FBA3998D4DF7

Q35588750-2DC8BF66-B3B6-41F2-BE7B-D91E99C99A41

Q35588750-592ED02C-9A76-4380-A8DD-C96FB99AFF60

Q35588750-67390D1C-A3A3-4A70-B769-B08D1017FDD4

Q35588750-7159E4D1-00E5-4CAD-A4F8-3773C5067EC9

Q35588750-7B8EA42F-A308-4E08-BEC8-43E461998716

Q35588750-7CBBA9EE-8A96-432C-9985-CDB38D672211

Q35588750-7CD3105C-4C91-4862-9EE6-3060CCE4BCE2

Q35588750-83C3CD6F-E15D-401D-8FF0-63CC3FBEEFBA

P304

Q35588750-352F828F-EA1B-43E4-87D2-3F4BC7CFBD81

P31

Q35588750-F8E40A26-00BC-488A-9B08-EE9FB2FDE031

P356

Q35588750-1300EA1B-BCDD-428D-BFFB-5F2B35CEBDCE

P407

Q35588750-BA29F10E-7E2C-44C8-A880-E5036466EC95

P433

Q35588750-2BFCF047-782A-48FB-9033-1130F7425C78

P478

Q35588750-C50B3182-A252-4FD8-86D2-70D78FDBB528

P577

Q35588750-188094C7-C715-49A2-B1F2-70CEC1D715A5

P5875

Q35588750-D784CC91-B6E0-492A-8204-D8B54120F216

P698

Q35588750-20FE3821-E70E-4E03-BCAC-C945ABE1109E

P932

Q35588750-EEDA7E80-2D74-486C-B5A3-CB2574478466

P356

JCP.2004.023648

P1433

Journal of Clinical Pathology

P1476

H19 expression in hepatic metastases from a range of human carcinomas.

@en

P2093

A Czerniak

http://www.w3.org/2001/XMLSchema#string

A Hochberg

http://www.w3.org/2001/XMLSchema#string

I Ariel

http://www.w3.org/2001/XMLSchema#string

I Sinelnikov

http://www.w3.org/2001/XMLSchema#string

N de Groot

http://www.w3.org/2001/XMLSchema#string

P Ohana

http://www.w3.org/2001/XMLSchema#string

P Schachter

http://www.w3.org/2001/XMLSchema#string

S Ayesh

http://www.w3.org/2001/XMLSchema#string

T Birman

http://www.w3.org/2001/XMLSchema#string

T Schneider

http://www.w3.org/2001/XMLSchema#string

P2860

The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.

H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression

Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer

Possible physiological role of H19 RNA

Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells

H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium

Loss of H19 imprinting in esophageal cancer

Interstitial ablative techniques for hepatic tumours.

Non-resection approaches for colorectal liver metastases.

P304

1064-1068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCP.2004.023648

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7575669

http://www.w3.org/2001/XMLSchema#string

P698

16189152

http://www.w3.org/2001/XMLSchema#string

P932

1770739

http://www.w3.org/2001/XMLSchema#string